JPMorgan Securities Plc Form 38.5(a) - Pfizer Inc (7746G)
November 24 2015 - 6:47AM
UK Regulatory
TIDMPFZ
RNS Number : 7746G
JPMorgan Securities Plc
24 November 2015
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT,
1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED
INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal J.P. Morgan Securities
trader plc
======================== ======================
Company dealt in Pfizer Inc
======================== ======================
Class of relevant Common Stock
security to which
the dealings being
disclosed relate
(Note 1)
======================== ======================
Date of dealing 23 November 2015
======================== ======================
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number Highest price paid Lowest price
of relevant (Note 3) paid
secuities (Note 3)
acquired
============= ========================= ===============
1,916 30.2750 EUR 29.9000 EUR
9,335 31.5900 USD 31.4800 USD
============= ========================= ===============
Total number Highest price received Lowest price
of securities (Note 3) received
disposed (Note 3)
=============== ============================= ===============
1,664 30.4300 EUR 29.4950 EUR
=============== ============================= ===============
(b) Derivatives transactions (other than options transactions)
Product Nature of Number of relevant Price per
name, transaction securities unit (EUR)
e.g. CFD (Note 4) (Note 5) (Note 3)
========== ============= =================== ============
Equity Long 1,664 30.0391
Swap
Short 1,664 30.1018
1,916
========== ============= =================== ============
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type, Expiry Option
name, selling, of securities price e.g. date money
e.g. purchasing, to which American, paid/received
call varying the option European per unit
option etc. relates etc. (Note
(Note 3)
5)
======== ============= ============== ========= =========== ====== ===============
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call per unit (Note
option 3)
============= =========================== ===================
Ap25
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities
under any option referred to on this form or relating to the
voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
Date of disclosure 24 November 2015
======================== ===================
Contact name Tung Le
======================== ===================
Telephone number 020 7742 7272
======================== ===================
Name of offeree/offeror Allergan Plc
with which connected
======================== ===================
Nature of connection Adviser to Allergan
(Note 6) Plc
======================== ===================
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEUSSARVSAAUAA
(END) Dow Jones Newswires
November 24, 2015 06:47 ET (11:47 GMT)
Pfizer (LSE:PFZ)
Historical Stock Chart
From Oct 2024 to Nov 2024
Pfizer (LSE:PFZ)
Historical Stock Chart
From Nov 2023 to Nov 2024